D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 15.3 CNY -5.9% Market Closed
Market Cap: 17.4B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
DaShenLin Pharmaceutical Group Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Cash Taxes Paid
(539)
(565)
(581)
(539)
(622)
(590)
(661)
(701)
(679)
(682)
(740)
(681)
(776)
(783)
(825)
(851)
(847)
(863)
(882)
(890)
(898)
(917)
(904)
(967)
(939)
(978)
(1 119)
(1 138)
(1 108)
(1 229)
(1 254)
Change in Working Capital
(1 844)
(1 943)
(2 019)
(2 262)
(2 284)
(2 394)
(2 526)
(2 716)
(2 839)
(3 032)
(2 979)
(2 969)
(3 024)
(3 263)
(3 319)
(3 554)
(3 721)
(3 730)
(4 016)
(4 174)
(3 908)
(3 960)
(4 400)
(4 271)
(4 641)
(4 839)
(4 906)
(4 923)
(5 859)
(6 287)
(6 715)
Cash from Operating Activities
496
N/A
502
+1%
497
-1%
545
+10%
648
+19%
511
-21%
553
+8%
663
+20%
874
+32%
1 119
+28%
1 286
+15%
1 462
+14%
1 708
+17%
1 779
+4%
1 759
-1%
1 966
+12%
1 954
-1%
2 145
+10%
2 066
-4%
1 833
-11%
1 555
-15%
1 708
+10%
2 237
+31%
2 411
+8%
3 757
+56%
3 843
+2%
3 815
-1%
4 160
+9%
3 174
-24%
3 648
+15%
3 464
-5%
Investing Cash Flow
Capital Expenditures
(307)
(327)
(394)
(427)
(669)
(718)
(739)
(781)
(554)
(506)
(434)
(290)
(501)
(554)
(530)
(536)
(792)
(859)
(969)
(1 151)
(1 295)
(1 325)
(1 210)
(1 151)
(1 035)
(1 314)
(1 968)
(2 104)
(1 797)
(1 599)
(1 829)
Other Items
(118)
(102)
(80)
(545)
(769)
(584)
(279)
276
237
94
(920)
(1 218)
(1 157)
(869)
(189)
65
(279)
(688)
(726)
(590)
327
172
162
126
(259)
(133)
(210)
(322)
(507)
(532)
(507)
Cash from Investing Activities
(425)
N/A
(428)
-1%
(474)
-11%
(972)
-105%
(1 437)
-48%
(1 302)
+9%
(1 018)
+22%
(505)
+50%
(317)
+37%
(411)
-30%
(1 354)
-229%
(1 508)
-11%
(1 659)
-10%
(1 423)
+14%
(720)
+49%
(471)
+35%
(1 071)
-127%
(1 547)
-44%
(1 695)
-10%
(1 740)
-3%
(968)
+44%
(1 152)
-19%
(1 048)
+9%
(1 025)
+2%
(1 294)
-26%
(1 447)
-12%
(2 178)
-51%
(2 426)
-11%
(2 303)
+5%
(2 130)
+8%
(2 336)
-10%
Financing Cash Flow
Net Issuance of Debt
149
78
154
(51)
106
69
4
147
(162)
(115)
826
561
704
820
(203)
(34)
1 451
1 226
1 252
1 281
(77)
309
545
571
686
403
70
(41)
119
279
760
Cash Paid for Dividends
(160)
(162)
(158)
(22)
(21)
(22)
(247)
(263)
(263)
(261)
(273)
(254)
(253)
(251)
(305)
(334)
(333)
(333)
(531)
(530)
(534)
(540)
(445)
(417)
(420)
(437)
(639)
(656)
(605)
(684)
(455)
Other
23
32
42
977
976
978
968
10
(12)
(7)
(8)
(9)
(30)
(74)
(66)
(78)
92
(128)
(424)
(735)
(1 000)
(1 080)
(924)
(897)
(1 200)
(1 168)
(1 101)
(1 059)
(1 164)
(1 133)
(1 271)
Cash from Financing Activities
12
N/A
(52)
N/A
38
N/A
905
+2 274%
1 061
+17%
1 025
-3%
725
-29%
(106)
N/A
(437)
-313%
(383)
+12%
546
N/A
298
-45%
420
+41%
496
+18%
(573)
N/A
(445)
+22%
1 209
N/A
765
-37%
296
-61%
17
-94%
(1 612)
N/A
(1 311)
+19%
(824)
+37%
(744)
+10%
(934)
-26%
(1 202)
-29%
(1 671)
-39%
(1 756)
-5%
(1 649)
+6%
(1 539)
+7%
(966)
+37%
Change in Cash
Net Change in Cash
82
N/A
22
-73%
62
+177%
478
+674%
272
-43%
234
-14%
261
+11%
52
-80%
120
+129%
324
+171%
478
+47%
252
-47%
469
+87%
851
+81%
466
-45%
1 050
+125%
2 092
+99%
1 363
-35%
667
-51%
109
-84%
(1 025)
N/A
(755)
+26%
366
N/A
642
+76%
1 529
+138%
1 194
-22%
(34)
N/A
(22)
+34%
(779)
-3 376%
(21)
+97%
162
N/A
Free Cash Flow
Free Cash Flow
188
N/A
176
-7%
103
-41%
118
+14%
(21)
N/A
(207)
-900%
(186)
+10%
(118)
+37%
319
N/A
613
+92%
852
+39%
1 172
+38%
1 206
+3%
1 225
+2%
1 229
+0%
1 430
+16%
1 162
-19%
1 286
+11%
1 097
-15%
682
-38%
260
-62%
384
+48%
1 027
+168%
1 260
+23%
2 722
+116%
2 529
-7%
1 846
-27%
2 055
+11%
1 377
-33%
2 049
+49%
1 634
-20%

See Also

Discover More